173 related articles for article (PubMed ID: 15545016)
21. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
Xie Y; Feng H; Peng S; Xiao J; Zhang J
Neurosci Lett; 2017 Jan; 636():190-195. PubMed ID: 27840145
[TBL] [Abstract][Full Text] [Related]
22. Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation.
Hartmann A; Veldhuis JD; Deuschle M; Standhardt H; Heuser I
Neurobiol Aging; 1997; 18(3):285-9. PubMed ID: 9263193
[TBL] [Abstract][Full Text] [Related]
23. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
24. Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease.
Mateo I; Infante J; Sánchez-Juan P; García-Gorostiaga I; Rodríguez-Rodríguez E; Vázquez-Higuera JL; Berciano J; Combarros O
Acta Neurol Scand; 2010 Feb; 121(2):136-8. PubMed ID: 19785642
[TBL] [Abstract][Full Text] [Related]
25. Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease.
Kuiper MA; van Kamp GJ; Bergmans PL; Scheltens P; Wolters EC
J Neural Transm Park Dis Dement Sect; 1993; 6(2):145-9. PubMed ID: 8117411
[TBL] [Abstract][Full Text] [Related]
26. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia.
Yanase T; Fukahori M; Taniguchi S; Nishi Y; Sakai Y; Takayanagi R; Haji M; Nawata H
Endocr J; 1996 Feb; 43(1):119-23. PubMed ID: 8732462
[TBL] [Abstract][Full Text] [Related]
27. Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer's and Parkinson's Disease.
García S; Amor-Gutiérrez O; Palomares-Albarrán M; Toyos-Rodríguez C; Cuetos F; Martínez C; Costa-García A; Fernández-Sánchez MT; de la Escosura-Muñiz A; Novelli A
Curr Alzheimer Res; 2021; 18(9):695-700. PubMed ID: 34789127
[TBL] [Abstract][Full Text] [Related]
28. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
[TBL] [Abstract][Full Text] [Related]
29. Growth factors decrease in subjects with mild to moderate Alzheimer's disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS).
Luppi C; Fioravanti M; Bertolini B; Inguscio M; Grugnetti A; Guerriero F; Rovelli C; Cantoni F; Guagnano P; Marazzi E; Rolfo E; Ghianda D; Levante D; Guerrini C; Bonacasa R; Solerte SB
Arch Gerontol Geriatr; 2009; 49 Suppl 1():173-84. PubMed ID: 19836631
[TBL] [Abstract][Full Text] [Related]
30. Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.
Ahlskog JE; Uitti RJ; Tyce GM; O'Brien JF; Petersen RC; Kokmen E
J Neurol Sci; 1996 Mar; 136(1-2):162-8. PubMed ID: 8815165
[TBL] [Abstract][Full Text] [Related]
31. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study.
Faux NG; Ellis KA; Porter L; Fowler CJ; Laws SM; Martins RN; Pertile KK; Rembach A; Rowe CC; Rumble RL; Szoeke C; Taddei K; Taddei T; Trounson BO; Villemagne VL; Ward V; Ames D; Masters CL; Bush AI
J Alzheimers Dis; 2011; 27(4):909-22. PubMed ID: 21891867
[TBL] [Abstract][Full Text] [Related]
32. Plasma homocysteine in Alzheimer's disease with or without co-morbid depressive symptoms.
Kitzlerová E; Fisar Z; Jirák R; Zvĕrová M; Hroudová J; Benaková H; Raboch J
Neuro Endocrinol Lett; 2014; 35(1):42-9. PubMed ID: 24625917
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone effects on cortisol secretion in Alzheimer's disease: some clinical and hormonal features in suppressor and nonsuppressor patients.
Murialdo G; Barreca A; Nobili F; Rollero A; Timossi G; Gianelli MV; Copello F; Rodriguez G; Polleri A
J Endocrinol Invest; 2000 Mar; 23(3):178-86. PubMed ID: 10803476
[TBL] [Abstract][Full Text] [Related]
34. Elevated plasma levels of homocysteine in Parkinson's disease.
Kuhn W; Roebroek R; Blom H; van Oppenraaij D; Przuntek H; Kretschmer A; Büttner T; Woitalla D; Müller T
Eur Neurol; 1998 Nov; 40(4):225-7. PubMed ID: 9813406
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease.
Kirbas S; Kirbas A; Tufekci A; Cumhur Cure M; Cakmak S; Yazici T; Cure E
Acta Clin Belg; 2016 Apr; 71(2):71-5. PubMed ID: 27075796
[TBL] [Abstract][Full Text] [Related]
36. Resistance of beta-endorphin to dexamethasone inhibition in Parkinson's and Alzheimer's diseases.
Airaghi L; Catania A; Gramigna C; Manfredi MG; Franceschi M; Zanussi C
Int J Neurosci; 1991; 56(1-4):73-9. PubMed ID: 1657808
[TBL] [Abstract][Full Text] [Related]
37. Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.
Irizarry MC; Yao Y; Hyman BT; Growdon JH; Praticò D
Neurodegener Dis; 2007; 4(6):403-5. PubMed ID: 17934322
[TBL] [Abstract][Full Text] [Related]
38. [Homocysteine and cognitive impairment in Parkinson's disease].
Martín-Fernández JJ; Carles-Díes R; Cañizares F; Parra S; Avilés F; Villegas I; Morsi-Hassan O; Fernández-Barreiro A; Herrero MT
Rev Neurol; 2010 Feb 1-15; 50(3):145-51. PubMed ID: 20146187
[TBL] [Abstract][Full Text] [Related]
39. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.
Anamnart C; Kitjarak R
J Clin Neurosci; 2021 Jun; 88():226-231. PubMed ID: 33992189
[TBL] [Abstract][Full Text] [Related]
40. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
